• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在围产期治疗中应用工程纳米材料。

Engineered nanomaterial applications in perinatal therapeutics.

机构信息

Environmental and Occupational Health Sciences Institute, 170 Frelinghuysen Rd., Piscataway, NJ 08854, USA.

Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, 160 Frelinghuysen Rd., Piscataway, NJ 08854, USA.

出版信息

Pharmacol Res. 2018 Apr;130:36-43. doi: 10.1016/j.phrs.2018.02.027. Epub 2018 Feb 23.

DOI:10.1016/j.phrs.2018.02.027
PMID:29477479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5965276/
Abstract

Engineered nanomaterials (ENM) are widely used in commercial, domestic, and more recently biomedical applications. While the majority of exposures to ENM are unintentional, biomedical platforms are being evaluated for use in individualized and/or tissue-targeted therapies. Treatments are often avoided during prenatal periods to reduce adverse effects on the developing fetus. The placenta is central to maternal-fetal medicine. Perturbation of placental functions can limit transfer of necessary nutrients, alter production of hormones needed during pregnancy, or allow undesired passage of xenobiotics to the developing fetus. The development of therapeutics to target specific maternal, placental, or fetal tissues would be especially important to reduce or circumvent toxicities. Therefore, this review will discuss the potential use of ENM in perinatal medicine, the applicable physiochemical properties of ENM in therapeutic use, and current methodologies of ENM testing in perinatal medicine, and identify maternal, fetal, and offspring concerns associated with ENM exposure during gestation. As potential nanoparticle-based therapies continue to develop, so does the need for thorough consideration and evaluation for use in perinatal medicine.

摘要

工程纳米材料(ENM)广泛应用于商业、家庭,最近也应用于生物医学领域。尽管大多数情况下人们接触 ENM 都是无意的,但生物医学平台正在被评估用于个体化和/或组织靶向治疗。为了减少对发育中胎儿的不良影响,通常避免在产前使用这些治疗方法。胎盘是母婴医学的核心。胎盘功能障碍会限制必要营养物质的转移,改变妊娠期间所需激素的产生,或者允许外源性物质不受控制地进入发育中的胎儿。开发针对特定母体、胎盘或胎儿组织的治疗方法尤为重要,可以减少或避免毒性。因此,本文将讨论 ENM 在围产期医学中的潜在应用、ENM 在治疗中的适用物理化学性质,以及目前在围产期医学中 ENM 测试的方法,并确定与妊娠期 ENM 暴露相关的母体、胎儿和后代问题。随着基于纳米颗粒的潜在治疗方法的不断发展,在围产期医学中使用这些方法需要进行全面的考虑和评估。

相似文献

1
Engineered nanomaterial applications in perinatal therapeutics.在围产期治疗中应用工程纳米材料。
Pharmacol Res. 2018 Apr;130:36-43. doi: 10.1016/j.phrs.2018.02.027. Epub 2018 Feb 23.
2
Gestational nanomaterial exposures: microvascular implications during pregnancy, fetal development and adulthood.妊娠期纳米材料暴露:孕期、胎儿发育及成年期的微血管影响
J Physiol. 2016 Apr 15;594(8):2161-73. doi: 10.1113/JP270581. Epub 2015 Oct 28.
3
Maternal engineered nanomaterial exposure and fetal microvascular function: does the Barker hypothesis apply?母体工程纳米材料暴露与胎儿微血管功能:巴克尔假说适用吗?
Am J Obstet Gynecol. 2013 Sep;209(3):227.e1-11. doi: 10.1016/j.ajog.2013.04.036. Epub 2013 Apr 30.
4
The Application of Engineered Nanomaterials in Perinatal Therapeutics.工程纳米材料在围产期治疗中的应用。
Small. 2024 Oct;20(41):e2303072. doi: 10.1002/smll.202303072. Epub 2023 Jul 12.
5
Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome.孕期母体吸入工程纳米材料会改变胎儿的转录组。
Part Fibre Toxicol. 2018 Jan 10;15(1):3. doi: 10.1186/s12989-017-0239-8.
6
Identification and quantification of gold engineered nanomaterials and impaired fluid transfer across the rat placenta via ex vivo perfusion.通过离体灌注鉴定和量化金工程纳米材料,并研究其对大鼠胎盘跨膜液体转运的影响。
Biomed Pharmacother. 2019 Sep;117:109148. doi: 10.1016/j.biopha.2019.109148. Epub 2019 Jul 4.
7
ROS promote epigenetic remodeling and cardiac dysfunction in offspring following maternal engineered nanomaterial (ENM) exposure.ROS 促进了母体工程纳米材料(ENM)暴露后后代的表观遗传重塑和心脏功能障碍。
Part Fibre Toxicol. 2019 Jun 18;16(1):24. doi: 10.1186/s12989-019-0310-8.
8
Nanomedicines: An approach to treat placental insufficiency and the current challenges.纳米药物:一种治疗胎盘功能不全的方法及其当前面临的挑战。
J Control Release. 2023 Aug;360:57-68. doi: 10.1016/j.jconrel.2023.06.003. Epub 2023 Jun 21.
9
Ecological nanotoxicology: integrating nanomaterial hazard considerations across the subcellular, population, community, and ecosystems levels.生态纳米毒理学:在亚细胞、种群、群落和生态系统水平上综合考虑纳米材料的危害。
Acc Chem Res. 2013 Mar 19;46(3):813-22. doi: 10.1021/ar300069t. Epub 2012 Oct 5.
10
Enhanced antioxidant capacity prevents epitranscriptomic and cardiac alterations in adult offspring gestationally-exposed to ENM.增强抗氧化能力可预防成年子代在妊娠期暴露于纳米材料下的心脏外转录组学和心脏改变。
Nanotoxicology. 2021 Aug;15(6):812-831. doi: 10.1080/17435390.2021.1921299. Epub 2021 May 8.

引用本文的文献

1
Nanomaterial Databases: Data Sources for Promoting Design and Risk Assessment of Nanomaterials.纳米材料数据库:促进纳米材料设计与风险评估的数据来源。
Nanomaterials (Basel). 2021 Jun 18;11(6):1599. doi: 10.3390/nano11061599.
2
Ionizable lipid nanoparticles for in utero mRNA delivery.用于子宫内mRNA递送的可电离脂质纳米颗粒。
Sci Adv. 2021 Jan 13;7(3). doi: 10.1126/sciadv.aba1028. Print 2021 Jan.
3
Translocation of (ultra)fine particles and nanoparticles across the placenta; a systematic review on the evidence of in vitro, ex vivo, and in vivo studies.

本文引用的文献

1
Carbon-Nanotube-Based Thermoelectric Materials and Devices.基于碳纳米管的热电材料与器件。
Adv Mater. 2018 Mar;30(11). doi: 10.1002/adma.201704386. Epub 2018 Jan 22.
2
Maternal engineered nanomaterial inhalation during gestation alters the fetal transcriptome.孕期母体吸入工程纳米材料会改变胎儿的转录组。
Part Fibre Toxicol. 2018 Jan 10;15(1):3. doi: 10.1186/s12989-017-0239-8.
3
Applications of functionalized nanomaterials in photodynamic therapy.功能化纳米材料在光动力疗法中的应用。
(超)细颗粒物和纳米颗粒穿过胎盘的转移;关于体外、离体和体内研究证据的系统评价。
Part Fibre Toxicol. 2020 Nov 2;17(1):56. doi: 10.1186/s12989-020-00386-8.
4
Recent insights on indirect mechanisms in developmental toxicity of nanomaterials.近期关于纳米材料发育毒性间接机制的研究进展。
Part Fibre Toxicol. 2020 Jul 11;17(1):31. doi: 10.1186/s12989-020-00359-x.
5
Uniform-sized insulin-loaded PLGA microspheres for improved early-stage peri-implant bone regeneration.载胰岛素的均一大小 PLGA 微球可改善种植体周围早期骨再生。
Drug Deliv. 2019 Dec;26(1):1178-1190. doi: 10.1080/10717544.2019.1682719.
6
Identification and quantification of gold engineered nanomaterials and impaired fluid transfer across the rat placenta via ex vivo perfusion.通过离体灌注鉴定和量化金工程纳米材料,并研究其对大鼠胎盘跨膜液体转运的影响。
Biomed Pharmacother. 2019 Sep;117:109148. doi: 10.1016/j.biopha.2019.109148. Epub 2019 Jul 4.
7
Knowledge Gaps and Emerging Research Areas in Intrauterine Growth Restriction-Associated Brain Injury.宫内生长受限相关脑损伤的知识空白与新兴研究领域
Front Endocrinol (Lausanne). 2019 Mar 29;10:188. doi: 10.3389/fendo.2019.00188. eCollection 2019.
8
Developmental onset of cardiovascular disease-Could the proof be in the placenta?心血管疾病的发生发展——胎盘里是否有答案?
Microcirculation. 2019 Nov;26(8):e12526. doi: 10.1111/micc.12526. Epub 2019 Jan 23.
9
Gold nanoparticle distribution in advanced in vitro and ex vivo human placental barrier models.金纳米颗粒在先进的体外和离体人胎盘屏障模型中的分布。
J Nanobiotechnology. 2018 Oct 11;16(1):79. doi: 10.1186/s12951-018-0406-6.
Biophys Rev. 2018 Feb;10(1):49-67. doi: 10.1007/s12551-017-0383-2. Epub 2018 Jan 2.
4
Nanotheranostics: Emerging Strategies for Early Diagnosis and Therapy of Brain Cancer.纳米诊疗学:脑癌早期诊断与治疗的新兴策略
Nanotheranostics. 2018 Jan 1;2(1):70-86. doi: 10.7150/ntno.21638. eCollection 2018.
5
Placental Drug Transport-on-a-Chip: A Microengineered In Vitro Model of Transporter-Mediated Drug Efflux in the Human Placental Barrier.胎盘药物输送芯片:人胎盘屏障中介体介导药物外排的微工程化体外模型。
Adv Healthc Mater. 2018 Jan;7(2). doi: 10.1002/adhm.201700786. Epub 2017 Nov 9.
6
Prenatal Air Pollution and Newborns' Predisposition to Accelerated Biological Aging.产前空气污染与新生儿加速生物衰老的易感性。
JAMA Pediatr. 2017 Dec 1;171(12):1160-1167. doi: 10.1001/jamapediatrics.2017.3024.
7
Changes in T Cell and Dendritic Cell Phenotype from Mid to Late Pregnancy Are Indicative of a Shift from Immune Tolerance to Immune Activation.从妊娠中期到晚期,T细胞和树突状细胞表型的变化表明从免疫耐受向免疫激活的转变。
Front Immunol. 2017 Sep 15;8:1138. doi: 10.3389/fimmu.2017.01138. eCollection 2017.
8
Tim-3 signaling in peripheral NK cells promotes maternal-fetal immune tolerance and alleviates pregnancy loss.Tim-3 信号在外周 NK 细胞中促进了母胎免疫耐受,缓解了妊娠丢失。
Sci Signal. 2017 Sep 26;10(498):eaah4323. doi: 10.1126/scisignal.aah4323.
9
IL‑33 restricts invasion and adhesion of trophoblast cell line JEG3 by downregulation of integrin α4β1 and CD62L.IL-33 通过下调整合素 α4β1 和 CD62L 来限制滋养细胞系 JEG3 的侵袭和黏附。
Mol Med Rep. 2017 Oct;16(4):3887-3893. doi: 10.3892/mmr.2017.7085. Epub 2017 Jul 26.
10
Maternal dendrimer-based therapy for inflammation-induced preterm birth and perinatal brain injury.基于树突状聚合物的母体疗法治疗炎症诱导的早产及围生期脑损伤。
Sci Rep. 2017 Jul 21;7(1):6106. doi: 10.1038/s41598-017-06113-2.